Patent details

EP3773713 Title: A LEPTIN RECEPTOR AGONIST ANTIBODY FOR USE IN INCREASING BONE MASS IN A SUBJECT SUFFERING FROM METABOLIC DYSFUNCTION OR HYPOLEPTINEMIA

Basic Information

Publication number:
EP3773713
PCT Application Number:
US2019026173
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197185622
PCT Publication Number:
WO2019195796
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A LEPTIN RECEPTOR AGONIST ANTIBODY FOR USE IN INCREASING BONE MASS IN A SUBJECT SUFFERING FROM METABOLIC DYSFUNCTION OR HYPOLEPTINEMIA
French Title of Invention:
ANTICORPS AGONISTE DU RÉCEPTEUR DE LA LEPTINE DESTINÉ À ÊTRE UTILISÉ DANS POUR AUGMENTER LA MASSE OSSEUSE CHEZ UN SUJET SOUFFRANT DE DYSFONCTIONNEMENT MÉTABOLIQUE OU D'HYPOLEPTINÉMIE
German Title of Invention:
LEPTINREZEPTOR-AGONISTEN-ANTIKÖRPER ZUR VERBESSERUNG DER KNOCHENMASSE BEI EINER PERSON, DIE AN EINER METABOLISCHEN DYSFUNKTION ODER HYPOLEPTINÄMIE LEIDET
SPC Number:

Dates

Filing date:
05/04/2019
Grant date:
09/07/2025
EP Publication Date:
17/02/2021
PCT Publication Date:
10/10/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/07/2025
EP B1 Publication Date:
09/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/04/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/07/2025
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
NLO
From:
18/07/2025
Address:
P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)
To:

Inventor

1

Name:
GROMADA, Jesper
Address:
United States (US)

2

Name:
MURPHY, Andrew J.
Address:
United States (US)

3

Name:
ALTAREJOS, Judith
Address:
United States (US)

4

Name:
STEVIS, Panayiotis
Address:
United States (US)

Priority

Priority Number:
201862653731 P
Priority Date:
06/04/2018
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61P 3/00; A61P 3/04; A61P 3/14;

Publication

European Patent Bulletin

Issue number:
202528
Publication date:
09/07/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2027
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/03/2026
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
14/07/2025 Power Of Attorney 1
18/07/2025 Outgoing Correspondence 1